U
Puration, Inc. PURA
$0.00 $0.000.00% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

Company Overview

Puration, Inc. (OTC Pink: PURA) is a publicly traded company that has historically focused on the development, marketing, and distribution of beverage products containing hemp-derived cannabidiol (CBD). Public disclosures and OTC market filings indicate that the company has positioned itself within the broader wellness, nutraceutical, and alternative beverage industries, particularly targeting the growing consumer market for infused functional beverages. The company has also referenced interests in lifestyle branding, cannabis-adjacent consumer products, and related intellectual property initiatives.

The company’s primary business activity has centered on CBD-infused beverage concepts and associated consumer wellness products. Publicly available information indicates that PURA has pursued strategic positioning around early participation in the hemp-derived beverage market following changes in U.S. hemp regulation after the 2018 Farm Bill. Historical company communications have referenced partnerships, licensing arrangements, and product development initiatives tied to cannabis and wellness sectors; however, the scale and current operational status of several initiatives are difficult to independently verify through recent audited filings. Data inconclusive based on available public sources regarding the company’s current revenue scale and active commercial operations.

Business Operations

Historically, Puration has described operations involving the development and commercialization of infused beverages, wellness products, and related branding initiatives. Company materials and OTC disclosures have referenced activities tied to beverage formulation, distribution relationships, and intellectual property licensing connected to CBD consumer products. Unlike larger consumer packaged goods companies, PURA has not publicly reported broad diversified operating segments in recent available disclosures, and available information suggests operations have remained relatively concentrated within cannabis-adjacent consumer products.

Public filings and OTC disclosures have also referenced affiliations or strategic relationships with entities operating in hemp, cannabis technology, and wellness markets. Certain announcements have mentioned collaborations involving cultivation, extraction technologies, and beverage commercialization; however, independently verifiable details regarding the financial materiality, duration, or operational impact of these relationships remain limited. Data inconclusive based on available public sources regarding major long-term joint ventures, significant subsidiaries, or internationally scaled operating assets.

Strategic Position & Investments

Puration’s stated strategic direction has historically emphasized participation in emerging hemp-derived consumer categories, especially CBD-infused beverages and wellness-oriented products. Public statements have highlighted interest in expanding through product launches, licensing opportunities, and strategic partnerships tied to cannabis-related consumer trends. The company has also referenced ambitions to participate in broader health and wellness markets through brand-building and commercialization strategies.

Available OTC disclosures and company communications have periodically referenced investments or relationships involving cannabis technology, agricultural initiatives, and beverage innovation platforms. However, publicly available audited financial information providing detailed verification of material acquisitions, portfolio company ownership, or large-scale capital investments appears limited. Data inconclusive based on available public sources regarding the current operational scale of previously announced initiatives or the financial performance of associated investments.

Geographic Footprint

Puration, Inc. is headquartered in the United States, with its historical market focus primarily concentrated on U.S. consumer markets tied to hemp-derived wellness and beverage products. Public company disclosures have generally emphasized domestic opportunities associated with evolving U.S. cannabis and hemp regulations rather than large-scale international expansion.

While certain company communications have referenced broader industry opportunities and potential international market relevance for CBD and wellness products, independently verified evidence of substantial operating infrastructure outside the United States remains limited. Data inconclusive based on available public sources regarding meaningful international revenue exposure or operational facilities across multiple continents.

Leadership & Governance

Publicly available information regarding Puration’s executive leadership and governance structure has varied over time, particularly due to the company’s status as an OTC-traded issuer with limited recent reporting transparency compared with SEC-reporting issuers listed on major exchanges. Historical disclosures and OTC market filings have identified executives associated with strategic development, corporate operations, and investor communications, although verification of current leadership roles should be cross-checked against the latest company filings and OTC disclosures.

Known or historically referenced leadership figures include:

  • Brian Shibley – Former Chief Executive Officer
  • Dr. Scott Dittman – Executive associated with corporate strategy and cannabis-sector initiatives

The company’s publicly communicated strategic vision has generally centered on early participation in emerging hemp and CBD consumer markets, with emphasis on wellness branding, beverage innovation, and leveraging evolving cannabis-related regulatory trends. Because recent independently verified governance disclosures appear limited, some executive and board information may no longer reflect current organizational leadership.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $217.55
B
AAPL NASDAQ $319.70
B
AVGO NASDAQ $368.79
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $103.09
Top Financial Stocks
See All »
B
B
JPM NYSE $357.62
B
V NYSE $381.60
Top Health Care Stocks
See All »
B
LLY NYSE $1,174.61
B
JNJ NYSE $268.04
B
ABBV NYSE $255.48
Top Real Estate Stocks
See All »
B
PLD NYSE $140.70
B
EQIX NASDAQ $1,044.41